| Volume 19 • Issue 6 |
March 20, 2019 |
|
|
|
|
 |
| |
DISCOVER NEW ORILISSA
|
|
|
AbbVie is proud to announce that new PrORILISSATM is now available in Canada. To discover more,
CLICK HERE
|
 |
|
|
| |
PrEUCRISATM - NOW AVAILABLE TO ORDER
|
|
|
Pfizer Canada is pleased to announce the launch and availability of PrEUCRISATM (crisaborole ointment 2%). EUCRISA is available in 60 gram tubes. To access EUCRISA Patient Information,
CLICK HERE
|
 |
|
|
 |
| |
TEMPORARY SHORTAGE OF RESTASIS® MULTIDOSE
|
|
|
Allergan Inc. would like to inform you that RESTASIS® MultiDose 0.05% Oph Emuls is expected to be on temporary shortage.
READ MORE
|
 |
|
|
| |
IMPORTANT INFORMATION - SHORTAGE OF RIFADIN® (rifampin)
|
|
|
Sanofi-aventis Canada Inc. would like to inform you that Rifadin® (rifampin) is expected to be on shortage.
READ MORE
|
 |
|
|
|
|
| |
PREVENTION AND TREATMENT OF IRON DEFICIENCY
|
|
|
|
| |
REMINDER - BEPREVETM IS AVAILABLE FOR ORDER
|
|
|
Help treat the itch associated with Allergic Conjunctivitis.
READ MORE
|
 |
|
| |
RECOMMEND SOOTHETM RESTORE (ADVANCED DRY EYE THERAPY)
|
|
|
Dry eye is a prevalent condition that may affect up to 29% of the Canadian population. Patients with dry eye often experience a number of symptoms (burning, irritation, itchiness, etc.) and are more likely to have a relatively thin lipid layer. Recommend SootheTM Restore to your patients – it moisturizes for fast relief, helps restore the lipid layer of tears and helps protect against tear loss.
READ MORE
|
 |
|
|
|
|
